Cytotrait Appoints Dr Ian Jepson as Non-Executive Director

MANCHESTER, England–(BUSINESS WIRE)–Cytotrait, a biotechnology company harnessing a unique organelle editing approach to develop new crop traits for food and agriculture, today announced the appointment of Dr Ian Jepson as a Non-Executive Director of the Company. With more than 36 years’ experience in global leadership and commercial growth, Dr Jepson will support the Company’s ongoing strategy to develop its proprietary Mutant Organelle Selection System (MOSS) platform, initiate new trait de

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.